NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan(Massachusetts General Hospital), Liron Bar‐Peled(Harvard University), Tzu-Yi Yang, Hannah Fischer, Marianne Richter, Magdy Gohar(Massachusetts General Hospital), Junbing Zhang(Massachusetts General Hospital), Ting-Yu Wei(Massachusetts General Hospital), Adriaan de Groot(Massachusetts General Hospital), Charles H. Adelmann(The University of Texas MD Anderson Cancer Center), Benedikt R. Dürr(Massachusetts General Hospital), Konstantin Wolf, Marcia C. Haigis(Harvard University), Mariko Takahashi(Massachusetts General Hospital), Maolin Ge(Shanghai Jiao Tong University), Cong-Hui Yao(Washington University in St. Louis), Tristan Vornbäumen(Massachusetts General Hospital), Thales Papagiannakopoulos(NYU Langone Health), Vindhya Vijay(Broad Institute), Raúl Mostoslavsky(Massachusetts General Hospital), Alexander Carlin(Massachusetts General Hospital), David E. Fisher(Dana-Farber Cancer Institute), Lei Shi(China Pharmaceutical University), Aaron N. Hata(Harvard University), Stefan Harry(Massachusetts General Hospital), Nabeel Bardeesy(Broad Institute), Makiko Hayashi(NYU Langone Health)
Cited by 21
Related Papers
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
|Signal Transduction and Targeted Therapy|2023|1.2k